Biopsy Evolved

SealJect plans to investigate use of hemostatic measures in sequence with performing traditional core needle biopsies.

A safer Biopsy

Biopsies are performed everyday to help physicians diagnose medical problems and guide lifesaving care but the procedure carries an inherent risk of complications. SealJect plans to investigate advanced technologies which may reduce these risks.

Use of Photopolymerization Gel

SealJect is developing a platform medical device to seal biopsy wounds using specialized photopolymerized gels.

New classes of hydrogels allow focused activation while being able to seal against high pressure bleeding.

Use of cautery

SealJect has begun development of a semi-automated biopsy gun which is able to cauterize biopsy wounds in sequence with traditional biopsy.

New types of cautery can rapidly cause hemostasis with minimal surrounding tissue damage.

SealJect has several pending patents applications which include:

Hardware
Sealants
Methods

About SealJect

SealJect was started by Dr. Joseph Burkett in Spring of 2022, after he was approached by nephrologists at Johns Hopkins University Hospital to make biopsy safer. Various methods were explored before deciding on use of Photopolymerized hydrogels and cautery.

Talk To Us!